Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AXAC
AXIOS Sustainable Growth Acquisition
$10.43
$10.43
$10.05
$10.95
$228.66M0.02N/AN/A
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
$2.93
-2.0%
$2.42
$1.76
$9.89
$370M0.2283,619 shs188,333 shs
IQMD
Intelligent Medicine Acquisition
$11.04
$10.72
$9.97
$11.22
$64.75M0.0348,072 shsN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.75
$11.80
$11.28
$11.95
$254.05M-0.0199,374 shs1 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AXAC
AXIOS Sustainable Growth Acquisition
0.00%0.00%0.00%0.00%0.00%
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
0.00%+14.90%+14.90%+50.26%+292,999,900.00%
IQMD
Intelligent Medicine Acquisition
0.00%0.00%0.00%0.00%0.00%
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
0.00%0.00%0.00%-1.09%+4.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AXAC
AXIOS Sustainable Growth Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
N/AN/AN/AN/AN/AN/AN/AN/A
IQMD
Intelligent Medicine Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AXAC
AXIOS Sustainable Growth Acquisition
0.00
N/AN/AN/A
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
0.00
N/AN/AN/A
IQMD
Intelligent Medicine Acquisition
0.00
N/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AXAC
AXIOS Sustainable Growth Acquisition
N/AN/AN/AN/AN/AN/A
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
N/AN/AN/AN/AN/AN/A
IQMD
Intelligent Medicine Acquisition
N/AN/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/A$0.40 per share29.45($0.64) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AXAC
AXIOS Sustainable Growth Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
N/AN/A0.00N/AN/AN/AN/AN/A
IQMD
Intelligent Medicine Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.44MN/A0.00N/AN/A-51.08%5.43%8/13/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AXAC
AXIOS Sustainable Growth Acquisition
N/AN/AN/AN/AN/A
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
N/AN/AN/AN/AN/A
IQMD
Intelligent Medicine Acquisition
N/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AXAC
AXIOS Sustainable Growth Acquisition
N/AN/AN/A
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
0.02
0.88
0.74
IQMD
Intelligent Medicine Acquisition
N/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/A
0.09
0.09
CompanyEmployeesShares OutstandingFree FloatOptionable
AXAC
AXIOS Sustainable Growth Acquisition
N/A21.92 millionN/ANot Optionable
GCL Global Holdings Ltd. stock logo
GCL
GCL Global
N/A126.28 million63.90 millionN/A
IQMD
Intelligent Medicine Acquisition
2,0215.87 million5.84 millionNot Optionable
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
221.62 million15.87 millionNot Optionable

Recent News About These Companies

Cartesian Growth Corporation II
Bertrand P. Grabowski's Net Worth
RENE’s Unexpected Plunge: What’s Next?
How to Take Advantage of moves in (RENE)

Media Sentiment Over Time

Top Headlines

View All Headlines

AXIOS Sustainable Growth Acquisition NYSE:AXAC

$10.43 0.00 (0.00%)
As of 06/27/2025

AXIOS Sustainable Growth Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to focus its search for a target business engaged in the agriculture, plant-based proteins, and related technology industry in Eastern Europe. The company was incorporated in 2021 and is based in Alpharetta, Georgia. AXIOS Sustainable Growth Acquisition Corporation operates as a subsidiary of AXIOS Sponsor LP.

GCL Global stock logo

GCL Global NASDAQ:GCL

$2.93 -0.06 (-2.01%)
As of 06/27/2025 04:00 PM Eastern

GCL Global Holdings Ltd. unites people through immersive games and entertainment experiences, enabling creators to deliver engaging content and fun gameplay experiences to gaming communities worldwide with a strategic focus on the rapidly expanding Asian gaming market. Drawing on a deep understanding of gaming trends and market dynamics, GCL Group leverages its diverse portfolio of digital and physical content to bridge cultures and audiences by introducing Asian-developed IP to a global audience across consoles, PCs, and streaming platforms.

Intelligent Medicine Acquisition NASDAQ:IQMD

Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.

Cartesian Growth Co. II stock logo

Cartesian Growth Co. II NASDAQ:RENE

$11.75 0.00 (0.00%)
As of 05/13/2025

Cartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY.